Travere Therapeutics Inc (TVTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TVTX? Forum Prognose Aktiensplit

Finanzdaten der Travere Therapeutics Inc-Aktie (TVTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.18% 41.37	45.06	37.09	32.20	30.89
Cost Of Revenue	67.05% 1.504	4.564	1.289	1.99	5.125
Gross Profit	1.54% 39.87	40.49	35.81	57.71	51.87
Operating Expenses	28.58% 179.11	139.29	129.68	136.15	128.26
Interest Income/Expense	0.00% 2.80	2.80	2.80	2.90	2.90
Benefits Costs and Expenses	32.60% 177.14	133.59	126.32	134.06	127.37
Costs And Expenses	29.66% 180.61	139.29	129.68	136.15	128.26
Operating Income/Loss	47.76% -139.24	-94.23	-92.58	-103.95	-97.37
Nonoperating Income/Loss	39.18% 3.47	5.705	3.356	2.016	0.793
Income/Loss From Continuing Operations Before Tax	53.36% -135.77	-88.53	-89.23	-101.87	-96.49
Income Tax Expense/Benefit	180.88% 0.191	0.068	0.012	0.065	0.078
Income/Loss From Continuing Operations After Tax	53.46% -135.96	-88.60	-89.24	-101.93	-96.56
Income/Loss From Discontinued Operations, Net Of Tax	93.47% -0.103	-1.577	239.98	16.30	10.23
Net Income/Loss	50.89% -136.06	-90.17	150.74	-85.63	-86.33
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	10,271% 77.14	0.7438	76.31	76.00	68.17
Diluted Average Shares	10,271% 77.14	0.7438	76.31	76.00	68.17
Basic Earnings Per Share	49.15% -1.76	-1.18	1.97	-1.13	-1.27
Diluted Earnings Per Share	49.15% -1.76	-1.18	1.97	-1.13	-1.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%